Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Overview

Journal Cancer Res

Specialty Oncology

Date 2023 Mar 19

PMID 36934744

Authors

Laura Privitera

Dale J Waterhouse

Alessandra Preziosi

Irene Paraboschi

Olumide Ogunlade

Chiara Da Pieve

Marta Barisa

Olumide Ogunbiyi

Gregory Weitsman

J Ciaran Hutchinson

Kate Cross

Lorenzo Biassoni

Danail Stoyanov

Neil Sebire

Paul Beard

Paolo De Coppi

Gabriela Kramer-Marek

John Anderson

Stefano Giuliani

Affiliations

Soon will be listed here.

Abstract

Significance: Multispectral near-infrared I/shortwave infrared fluorescence imaging is a versatile system enabling high tumor-to-background signal for safer and more complete resection of pediatric tumors during surgery.

Citing Articles

Systematic comparison of fluorescence imaging in the near-infrared and shortwave-infrared spectral range using clinical tumor samples containing cetuximab-IRDye800CW.

Keizers B, Nijboer T, van der Fels C, van den Heuvel M, van Dam G, Kruijff S J Biomed Opt. 2024; 30(Suppl 1):S13708.

PMID: 39553388 PMC: 11566260. DOI: 10.1117/1.JBO.30.S1.S13708.

Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging.

Tian Y, Shen H, Li L, Jia X, Liu J, Hu Z Eur J Nucl Med Mol Imaging. 2024; 51(9):2569-2582.

PMID: 38647671 DOI: 10.1007/s00259-024-06714-w.

Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors.

Giuliani S, Paraboschi I, McNair A, Smith M, Rankin K, Elson D Cancers (Basel). 2024; 16(5.

PMID: 38473402 PMC: 10931077. DOI: 10.3390/cancers16051045.

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [Cu]Cu-NOTA-ch14.18/CHO.

Trautwein N, Schwenck J, Seitz C, Seith F, Calderon E, von Beschwitz S Theranostics. 2024; 14(3):1212-1223.

PMID: 38323317 PMC: 10845206. DOI: 10.7150/thno.92481.

Machine Learning-Assisted Short-Wave InfraRed (SWIR) Techniques for Biomedical Applications: Towards Personalized Medicine.

Salimi M, Roshanfar M, Tabatabaei N, Mosadegh B J Pers Med. 2024; 14(1).

PMID: 38248734 PMC: 10817559. DOI: 10.3390/jpm14010033.

References

Park J, Eggert A, Caron H . Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010; 24(1):65-86. DOI: 10.1016/j.hoc.2009.11.011. View

Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K . Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016; 5(1):e1025194. PMC: 4760299. DOI: 10.1080/2162402X.2015.1025194. View

Zhu S, Yung B, Chandra S, Niu G, Antaris A, Chen X . Near-Infrared-II (NIR-II) Bioimaging Off-Peak NIR-I Fluorescence Emission. Theranostics. 2018; 8(15):4141-4151. PMC: 6096392. DOI: 10.7150/thno.27995. View

Hagenbuch B . Drug uptake systems in liver and kidney: a historic perspective. Clin Pharmacol Ther. 2009; 87(1):39-47. PMC: 2819296. DOI: 10.1038/clpt.2009.235. View

Nazha B, Inal C, Owonikoko T . Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Front Oncol. 2020; 10:1000. PMC: 7358363. DOI: 10.3389/fonc.2020.01000. View

Antaris A, Chen H, Diao S, Ma Z, Zhang Z, Zhu S . A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging. Nat Commun. 2017; 8:15269. PMC: 5454457. DOI: 10.1038/ncomms15269. View

Carr J, Franke D, Caram J, Perkinson C, Saif M, Askoxylakis V . Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc Natl Acad Sci U S A. 2018; 115(17):4465-4470. PMC: 5924901. DOI: 10.1073/pnas.1718917115. View

Zhu S, Tian R, Antaris A, Chen X, Dai H . Near-Infrared-II Molecular Dyes for Cancer Imaging and Surgery. Adv Mater. 2019; 31(24):e1900321. PMC: 6555689. DOI: 10.1002/adma.201900321. View

Privitera L, Paraboschi I, Cross K, Giuliani S . Above and Beyond Robotic Surgery and 3D Modelling in Paediatric Cancer Surgery. Front Pediatr. 2022; 9:777840. PMC: 8721224. DOI: 10.3389/fped.2021.777840. View

10.

Tummers W, Warram J, van den Berg N, Miller S, Swijnenburg R, Vahrmeijer A . Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics. 2018; 8(19):5336-5347. PMC: 6276089. DOI: 10.7150/thno.27384. View

11.

Fischer J, Pohl A, Volland R, Hero B, Dubbers M, Cernaianu G . Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017; 17(1):520. PMC: 5543757. DOI: 10.1186/s12885-017-3493-0. View

12.

Rich B, McEvoy M, Kelly N, Oh E, Abramson S, Price A . Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg. 2011; 46(1):103-7. DOI: 10.1016/j.jpedsurg.2010.09.075. View

13.

Zhu S, Hu Z, Tian R, Yung B, Yang Q, Zhao S . Repurposing Cyanine NIR-I Dyes Accelerates Clinical Translation of Near-Infrared-II (NIR-II) Bioimaging. Adv Mater. 2018; :e1802546. DOI: 10.1002/adma.201802546. View

14.

Hartmans E, Tjalma J, Linssen M, Allende P, Koller M, Jorritsma-Smit A . Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy. Theranostics. 2018; 8(6):1458-1467. PMC: 5858160. DOI: 10.7150/thno.22033. View

15.

Tummers W, Miller S, Teraphongphom N, Gomez A, Steinberg I, Huland D . Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. Ann Surg Oncol. 2018; 25(7):1880-1888. PMC: 5977989. DOI: 10.1245/s10434-018-6453-2. View

16.

Sterkenburg A, Hooghiemstra W, Schmidt I, Ntziachristos V, Nagengast W, Gorpas D . Standardization and implementation of fluorescence molecular endoscopy in the clinic. J Biomed Opt. 2022; 27(7). PMC: 8847121. DOI: 10.1117/1.JBO.27.7.074704. View

17.

von Allmen D, Davidoff A, London W, Van Ryn C, Haas-Kogan D, Kreissman S . Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. J Clin Oncol. 2016; 35(2):208-216. PMC: 5455676. DOI: 10.1200/JCO.2016.67.2642. View

18.

Waterhouse D, Fitzpatrick C, Pogue B, OConnor J, Bohndiek S . A roadmap for the clinical implementation of optical-imaging biomarkers. Nat Biomed Eng. 2019; 3(5):339-353. DOI: 10.1038/s41551-019-0392-5. View

19.

Barone G, Barry A, Bautista F, Brichard B, Defachelles A, Herd F . Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance. Paediatr Drugs. 2021; 23(6):537-548. PMC: 8563639. DOI: 10.1007/s40272-021-00469-9. View

20.

Paraboschi I, De Coppi P, Stoyanov D, Anderson J, Giuliani S . Fluorescence imaging in pediatric surgery: State-of-the-art and future perspectives. J Pediatr Surg. 2020; 56(4):655-662. DOI: 10.1016/j.jpedsurg.2020.08.004. View